News Author: Andrew D. Bowser Publish date: December 2, 2018
SAN DIEGO – Among patients who had complete remissions, 66% were still in remission at 18 months, overall survival was 70%, and median overall surv...
News Author: Andrew D. Bowser Publish date: December 1, 2018
SAN DIEGO – Luspatercept also showed promise in a phase 3 trial including adults with beta-thalassemia.
Video Author: Andrew D. Bowser Publish date: December 1, 2018
SAN DIEGO – Patients with no history of hematopoietic cell transplant may benefit from consolidation after receiving a CD19-specific CAR T-cell pro...
News Author: Andrew D. Bowser Publish date: December 1, 2018
SAN DIEGO – Hydroxyurea was associated with reduced rates of malaria and in other infections, resulting in improved survival.
News Author: Andrew D. Bowser Publish date: November 27, 2018
SAN DIEGO – A smartphone app with artificial intelligence elements improved pain outcomes and reduced hospital admiss...
News Author: Andrew D. Bowser Publish date: November 25, 2018
Sickle cell disease (SCD) will take center stage at the 2018 ASH Annual Meeting, according to a recent press briefing. During the briefing, ASH Pre...
News Author: Andrew D. Bowser Publish date: November 24, 2018
Several studies set to be presented at the 2018 ASH Annual Meeting provide new insights regarding chimeric antigen receptor (CAR) T-cell therapies....
News Author: Andrew D. Bowser Publish date: November 23, 2018
A retrospective study suggests haploidentical hematopoietic stem cell transplant (haplo-HSCT) is feasible in patients with multiply relapsed or high-r...
News Author: Andrew D. Bowser Publish date: November 21, 2018
Two probiotic products with Lactobacillus rhamnosus strains did not top placebo at preventing moderate t...
News Author: Andrew D. Bowser Publish date: November 21, 2018
Two probiotic products with Lactobacillus rhamnosus strains did not top placebo at preventing moderate t...
News Author: Andrew D. Bowser Publish date: November 21, 2018
New studies highlight the role of CAR T-cell therapies in CLL, ALL, and DLBCL.
News Author: Andrew D. Bowser Publish date: November 21, 2018
Dr. Alexis Thompson, ASH president, highlighted four top studies that will be presented at the meeting.
News Author: Andrew D. Bowser Publish date: November 21, 2018
Phase 3 results suggest the biosimilar product CT-P10 is equivalent to rituximab in patients with low-tumor-burden follicular lymphoma (FL). Overal...
News Author: Andrew D. Bowser Publish date: November 20, 2018
SAN DIEGO - Oncologists spent on average 3 minutes less with minority patients than with nonminority patients discussing a scan result related to a...
News Author: Andrew D. Bowser Publish date: November 19, 2018
Dementia was associated with mortality in 70% of older adults with Down syndrome.
